These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 20820094)

  • 21. Relaxometric and magnetic characterization of ultrasmall iron oxide nanoparticles with high magnetization. Evaluation as potential T1 magnetic resonance imaging contrast agents for molecular imaging.
    Taboada E; Rodríguez E; Roig A; Oró J; Roch A; Muller RN
    Langmuir; 2007 Apr; 23(8):4583-8. PubMed ID: 17355158
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Degradation of magnetic nanoparticles mimicking lysosomal conditions followed by AC susceptibility.
    Gutiérrez L; Romero S; da Silva GB; Costo R; Vargas MD; Ronconi CM; Serna CJ; Veintemillas-Verdaguer S; Del Puerto Morales M
    Biomed Tech (Berl); 2015 Oct; 60(5):417-25. PubMed ID: 26035106
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A systematic study of transfection efficiency and cytotoxicity in HeLa cells using iron oxide nanoparticles prepared with organic and inorganic bases.
    Calmon MF; de Souza AT; Candido NM; Raposo MI; Taboga S; Rahal P; Nery JG
    Colloids Surf B Biointerfaces; 2012 Dec; 100():177-84. PubMed ID: 22766295
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cellular level loading and heating of superparamagnetic iron oxide nanoparticles.
    Kalambur VS; Longmire EK; Bischof JC
    Langmuir; 2007 Nov; 23(24):12329-36. PubMed ID: 17960940
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relaxation behavior study of ultrasmall superparamagnetic iron oxide nanoparticles at ultralow and ultrahigh magnetic fields.
    Wang W; Dong H; Pacheco V; Willbold D; Zhang Y; Offenhaeusser A; Hartmann R; Weirich TE; Ma P; Krause HJ; Gu Z
    J Phys Chem B; 2011 Dec; 115(49):14789-93. PubMed ID: 21972868
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pheomelanin-coated iron oxide magnetic nanoparticles: a promising candidate for negative T2 contrast enhancement in magnetic resonance imaging.
    Zottis AD; Beltrame JM; Lara LR; Costa TG; Feldhaus MJ; Pedrosa RC; Ourique F; de Campos CE; Isoppo Ede A; da Silva Miranda F; Szpoganicz B
    Chem Commun (Camb); 2015 Jun; 51(56):11194-7. PubMed ID: 26073290
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stability of superparamagnetic iron oxide nanoparticles at different pH values: experimental and theoretical analysis.
    Park Y; Whitaker RD; Nap RJ; Paulsen JL; Mathiyazhagan V; Doerrer LH; Song YQ; Hürlimann MD; Szleifer I; Wong JY
    Langmuir; 2012 Apr; 28(15):6246-55. PubMed ID: 22409538
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Folic acid-Pluronic F127 magnetic nanoparticle clusters for combined targeting, diagnosis, and therapy applications.
    Lin JJ; Chen JS; Huang SJ; Ko JH; Wang YM; Chen TL; Wang LF
    Biomaterials; 2009 Oct; 30(28):5114-24. PubMed ID: 19560199
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthetic routes to magnetic nanoparticles for MPI.
    Kratz H; Eberbeck D; Wagner S; Taupitz M; Schnorr J
    Biomed Tech (Berl); 2013 Dec; 58(6):509-15. PubMed ID: 23950566
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dendronized iron oxide nanoparticles as contrast agents for MRI.
    Basly B; Felder-Flesch D; Perriat P; Billotey C; Taleb J; Pourroy G; Begin-Colin S
    Chem Commun (Camb); 2010 Feb; 46(6):985-7. PubMed ID: 20107672
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A pharmaceutical study of doxorubicin-loaded PEGylated nanoparticles for magnetic drug targeting.
    Gautier J; Munnier E; Paillard A; Hervé K; Douziech-Eyrolles L; Soucé M; Dubois P; Chourpa I
    Int J Pharm; 2012 Feb; 423(1):16-25. PubMed ID: 21703340
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Carbodiimide versus click chemistry for nanoparticle surface functionalization: a comparative study for the elaboration of multimodal superparamagnetic nanoparticles targeting αvβ3 integrins.
    Bolley J; Guenin E; Lievre N; Lecouvey M; Soussan M; Lalatonne Y; Motte L
    Langmuir; 2013 Nov; 29(47):14639-47. PubMed ID: 24171381
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Amorphous silica coatings on magnetic nanoparticles enhance stability and reduce toxicity to in vitro BEAS-2B cells.
    Baber O; Jang M; Barber D; Powers K
    Inhal Toxicol; 2011 Aug; 23(9):532-43. PubMed ID: 21819260
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Design of water-based ferrofluids as contrast agents for magnetic resonance imaging.
    Casula MF; Corrias A; Arosio P; Lascialfari A; Sen T; Floris P; Bruce IJ
    J Colloid Interface Sci; 2011 May; 357(1):50-5. PubMed ID: 21345440
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nanomagnetism reveals the intracellular clustering of iron oxide nanoparticles in the organism.
    Levy M; Wilhelm C; Luciani N; Deveaux V; Gendron F; Luciani A; Devaud M; Gazeau F
    Nanoscale; 2011 Oct; 3(10):4402-10. PubMed ID: 21931920
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Magnetic nanoparticles as contrast agents in biomedical imaging: recent advances in iron- and manganese-based magnetic nanoparticles.
    Felton C; Karmakar A; Gartia Y; Ramidi P; Biris AS; Ghosh A
    Drug Metab Rev; 2014 May; 46(2):142-54. PubMed ID: 24754519
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Europium-engineered iron oxide nanocubes with high T1 and T2 contrast abilities for MRI in living subjects.
    Yang L; Zhou Z; Liu H; Wu C; Zhang H; Huang G; Ai H; Gao J
    Nanoscale; 2015 Apr; 7(15):6843-50. PubMed ID: 25806860
    [TBL] [Abstract][Full Text] [Related]  

  • 38. One-pot, exchange-free, room-temperature synthesis of sub-10 nm aqueous, noninteracting, and stable zwitterated iron oxide nanoparticles.
    Estephan ZG; Hariri HH; Schlenoff JB
    Langmuir; 2013 Feb; 29(8):2572-9. PubMed ID: 23394134
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Folate-targeting magnetic core-shell nanocarriers for selective drug release and imaging.
    Wang H; Wang S; Liao Z; Zhao P; Su W; Niu R; Chang J
    Int J Pharm; 2012 Jul; 430(1-2):342-9. PubMed ID: 22525087
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biodegradation mechanisms of iron oxide monocrystalline nanoflowers and tunable shield effect of gold coating.
    Javed Y; Lartigue L; Hugounenq P; Vuong QL; Gossuin Y; Bazzi R; Wilhelm C; Ricolleau C; Gazeau F; Alloyeau D
    Small; 2014 Aug; 10(16):3325-37. PubMed ID: 24797733
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.